Why the study?
Does Right Ventricular Ejection Fraction predict major adverse cardiovascular and heart failure-related events in patients with known or suspected cardiovascular disease?
Does Right Ventricular Ejection Fraction predict major adverse cardiovascular and heart failure-related events in patients with known or suspected cardiovascular disease?
Answers are grounded in this paper and cite their sources.
RVEF assessment provides independent prognostic value for major adverse cardiac events, supporting routine biventricular phenotyping for risk classification.
RVEF is a powerful and independent predictor of major adverse cardiac events with broad generalizability across patients with known or suspected cardiovascular disease. These findings support migration towards biventricular phenotyping for the classification of risk in clinical practice. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT04367220.
No takes yet. Share an insight, caveat, or question.
Purmah et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: